1. Li Zheng, Huirong Ding, Zheming Lu, Yong Li, Yaqi Pan, Tao Ning, Yang Ke (2008) E3 ubiquitin ligase E6AP-mediated TSC2 turnover . Genes to Cells (13):285-294.
2. Wenjun Yang, Yanyan Zhang, Xiuyun Tian, Tao Ning,Yang Ke (2008) p53 Codon 72 polymorphism and the risk of esophageal squamous cell. Molecular Carcinogenesis 47:100-104.
3. Y Zhou,Y Pan,S Zhang,X Shi,T Ning and Y Ke (2007) Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. British Journal of Cancer 16;97(2):218-22.
4. You Wang, Jiangying Liu, Hong Zhao, Wenqing Lü , Jun Zhao, Lin Yang, Ning Li, Xiaojuan Du*, Yang Ke (2007) Human 1A6/DRIM, the homolog of yeast Utp20,functions in the 18S rRNA processing. Biochimica et Biophysica Acta 1773: 863–868.
5. Jiangying Liu, Xiaojuan Du, Yang Ke (2006) Mapping nucleolar localization sequences of 1A6/DRIM. FEBS Letters580: 1405–1410.
6. Li,Z., Chen,D., Zhang,C., Li,Y., Cao, B., Ning,T., Zhao,Y., You,W., Ke,Y (2005). HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population, China. Immunogenetics.56(11):781-787.
7. Xing,X., Du,X., Lu,Z., Ning,T., Su,X., Ke,Y (2005). Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator. Gene. 3;344:161-169.
8. Cao,B., Tian,X., Li,Y., Jiang, P., Ning, T., Xing, H., Zhao, Y., Zhang, C., Shi, X., Chen, D., Shen, Y., Ke, Y (2005). LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis. 26(7):1280-1284.
9. Yang L, Zhao J, Lu W, Li Y, Du X, Ning T, Lu G, Ke Y. (2005). KIAA0649, a 1A6/DRIM-interacting protein with the oncogenic potential. Biochem Biophys Res Commun. 2005, 334:884-890.
10. Lu, ZM., Hu, XH., Li, Y., Ning, T., Ke,Y(2004). Human papillomavirus 16 E6 oncoprotein binds to tuberin and abrogates its function in insulin signaling pathway. J.Biol.Chem. 279:35664-35670.
11. Ya-Guang Xi, Ke-Yue Ding,Xiu-Lan Su, Da-Fang Chen, Wei-Cheng You, Yan Shen, Yang Ke(2004).P53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. Carcinogenesis. 25(11):2201-2206.
12. Zhu,WG., Hileman T., Ke,Y., Wang,P., Lu, S., Duan, W., Dai, Z., Tong, T., Villalona-Calero MA, Plass C, Otterson GA(2004). 5-aza-2-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. J Biol Chem. 279: 15161-15166.
13. Liu YQ, Zhao H, Ning T, Ke, Y, Li JY(2003) Expression of 1A6 gene and its correlation with intestinal gastric carcinoma. World J Gastroenterol 9(2):238-241.
14. Wu,QJ., Guo,M., Lu,ZM., Li,T., Qiao,HZ., Ke,Y(2003). Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer. 89(4): 672-5.
15. Ke,Y(2003), Papilloma Virus and Human Cancers.(Review) J Peking University (Health Sciences) .34(5):599-603.
16. Li T, Zh Lu, M Guo, Q Wu, K Chen, H Xing, Q Mei, Ke, Y(2002) p53 Codon 72 Polymorphism (C/G) and the Risk of Human Papillomavirus-Associated Carcinomas in China. Cancer 95(12): 2571-2576.
17. Xi,YG, Ding KY, Ren YH, Shen Y, Ke, Y(2002) Esophageal cancer in Chinese population: no polymorphism in codon 149 of p21 Waf1/Cip1 cyclin dependent kinase gene. Oncogene.21:7745-7748.
18. T Li, Zh Lu, K Chen, M Guo,H Xing, Q Mei, H Yang,J F.Lechner, Ke,Y (2001) Human papillomavirus type 16 is an important infectous factor for the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis. 22 (6): 929-934.
19. Ke,Y (2001).Heredity of Human Cancer(Review) J Peking University(Health Sciences) 33 (5):385-388.
| 
